1. Home
  2. FKWL vs CRBP Comparison

FKWL vs CRBP Comparison

Compare FKWL & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Franklin Wireless Corp.

FKWL

Franklin Wireless Corp.

HOLD

Current Price

$4.44

Market Cap

53.5M

Sector

Utilities

ML Signal

HOLD

Logo Corbus Pharmaceuticals Holdings Inc.

CRBP

Corbus Pharmaceuticals Holdings Inc.

HOLD

Current Price

$9.80

Market Cap

202.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FKWL
CRBP
Founded
1981
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.5M
202.6M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
FKWL
CRBP
Price
$4.44
$9.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$6.00
$50.29
AVG Volume (30 Days)
11.6K
513.0K
Earning Date
11-14-2025
11-12-2025
Dividend Yield
0.88%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$45,508,949.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$13.49
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
32.05
N/A
52 Week Low
$3.67
$4.64
52 Week High
$7.45
$20.56

Technical Indicators

Market Signals
Indicator
FKWL
CRBP
Relative Strength Index (RSI) 44.81 34.73
Support Level $4.41 $9.44
Resistance Level $4.65 $11.64
Average True Range (ATR) 0.14 0.74
MACD 0.00 -0.02
Stochastic Oscillator 58.81 12.16

Price Performance

Historical Comparison
FKWL
CRBP

About FKWL Franklin Wireless Corp.

Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: